FDA Alert Regarding Lupus Medication: a Hospital for Special Surgery Rheumatology Perspective

Progressive Multifocal Leukoencephalopathy (PML) in Patients Treated with Mycophenolate mofetil (CellCept)

On April 10, 2008, the FDA released a safety alert concerning a possible relationship between CellCept (mycophenolate mofetil) and a devastating neurological disease known as progressive multifocal leukoencephalopathy (PML).

Read full article

View the FDA alert